The Impossible QALY and the Denial of Fundamental Measurement: Rejecting the University of Washington Value Assessment of Targeted Immune Modulators (TIMS) in Ulcerative Colitis for the Institute for Clinical and Economic Review (ICER)
All too often organizations embrace standards for health technology assessment that fail to meet the standards of normal science. A continuing puzzle is why the axioms of fundamental measurement are ignored by researchers such as the University of Washington Model Group in constructing lifetime cost...
Saved in:
Main Author: | Paul Langley (Author) |
---|---|
Format: | Book |
Published: |
University of Minnesota Libraries Publishing,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ICER, ISPOR AND QALYs: A Tale of Imaginary Worlds
by: Paul Langley
Published: (2019) -
Value Assessment in Cystic Fibrosis: ICER's Rejection of the Axioms of Fundamental Measurement
by: Paul Langley
Published: (2020) -
Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
by: Paul C Langley
Published: (2022) -
Where Ignorance Is Bliss: The Institute for Clinical and Economic Review (ICER), The University of Washington, College of Pharmacy CHOICE Institute and Simulation Pricing and Access Recommendations for Atopic Dermatitis
by: Paul C Langley
Published: (2021) -
CVS Health and the Imaginary Worlds of the Institute for Clinical and Economic Review (ICER)
by: Paul Langley
Published: (2018)